Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
14,924,359
-
Share change
-
+399,641
-
Total reported value
-
$76,044,039
-
Price per share
-
$5.10
-
Number of holders
-
42
-
Value change
-
+$1,681,413
-
Number of buys
-
11
-
Number of sells
-
26
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2017
As of 31 Dec 2017,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,924,359 shares.
The largest 10 holders included
Paradice Investment Management LLC, JANUS HENDERSON GROUP PLC, HEARTLAND ADVISORS INC, Russell Investments Group, Ltd., Lapides Asset Management, LLC, Boston Partners, FIRST WILSHIRE SECURITIES MANAGEMENT INC, Senvest Management, LLC, 22NW, LP, and STONEHILL CAPITAL MANAGEMENT LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.